Antibiotic sensitivity and treatment recommendations for Streptococcus pneumoniae;Sensibilidad antibiótica y recomendaciones de tratamiento para Streptococcus pneumoniae

Anales del Sistema Sanitario de Navarra

Volumn 27, Issue 1, 2004, Pages 37-43

  Gil Setas, Alberto ^a   Mazon A ^a   Torroba, L ^b   Barricarte, A ^c   Garcia Irure J J ^b   Petit, A ^d   Polo, M E ^e  

^a Laboratorio de Microbiologia   (Spain)

^b Instituto de Investigación Sanitaria de Navarra   (Spain)

^c INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^d HOSPITAL GARCÍA ORCOYEN   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Antibiotic susceptibility; Beta lactams; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CHILD; CLINICAL PRACTICE; EAR INFECTION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; OTITIS MEDIA; PEDIATRICS; PRACTICE GUIDELINE; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 2542445304     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. HODGES RG, MACLEOD CM, BERNHARD WG. Epidemic pneumococcal pneumonia. III. Pneumococcal carrier studies. Am J Hyg 1946; 44: 207-230.
2. GRAY BM, CONVERSE GM, DILLON HC JR. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142: 923-933.
3. APPELBAUM PC, GLADKOVA C, HRYNIEWICZ W, KOJOUHAROV B, KOTULOVA D, MIHALCU F et al. Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and Central Europe. A multicenter study with use of standardized methods. Clin Infect Dis 1996; 23: 712-717.
4. VAQUEIRO M, SAMPERE M, FONT B, SERRATE G, FONTANALS D, SEGURA F. Pneumococcal bacteremia in patients aged over 65 years. A study of 161 cases. Med Clin 2001; 117: 241-245.
5. FILE TM JR. Appropiate use of antimicrobials for drug-resistant pneumonia: focus on the significance of b-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis 2002; 34: S17-26.
6. HANSMAN D, BULLEN MM. A resistant pneumococcus. Lancet 1967; 2: 264-265.
7. CASAL J. Antimicrobial susceptibility of streptococcus pneumoniae serotype distribution of penicillin-resistant strains in Spain. Antimicrob Agents Chemother 1982; 22: 222-225.
8. APPLEBAUM PC. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol 1987; 6: 367-377.
9. FEIKIN DR, SCHUCHAT A, KOLCZAK M, BARRETT NL, HARRISON LH, LEFKOWITZ L et al. Mortality from invasive pneumococcal pneumonia in an era of antibiotic resistance. 1995-1997. Am J Public Health 2000; 90: 223-229.
10. Performance Standards for Antimicrobial Susceptibility Testing Eleventh Informational Suplement. NCCLS January 2002; M100-S12 vol, 21 No 1.
11. FENOLL A, MARTÍN-BOURGON C, MUÑOZ R, VICIOSO D, CASAL J. Serotypes distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13: 56-60.
12. BAQUERO F, GARCÍA-RODRIGUEZ MA, GARCÍA J, AGUILAR L and the spanish surveillance group for respiratory pathogens. Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of 1-year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999; 43: 357-359.
13. FENOLL A, JADO I, Vicioso D, PEREZ A, CASAL J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36: 3447-3454.
14. NAVARRO C, EGIDO P, ASPÍROZ C, DURÁN E, GARCÍA C, RUBIO C et al. Resistencia a penicilina y otros antimicrobianos en 301 aislamientos clínicos de Streptococcus pneumoniae. Enferm Infec Microbiol Clin 2000; 18: 314-318.
15. Annual report EARSS 200. EARSS management team and national representatives of EARSS. Bilthoven (NL), March 2001.
16. LATORRE C, SIERRA M, LITE J. Estudio prospectivo de los aislamientos invasivas de Streptococcus pneumoniae aisladas en 16 hospitales de Cataluña durante 1996. Enferm Infecc Microbiol Clin 1999; 17: 286-291.
17. BAQUERO F, BAQUERO-ARTIGAS G, CANTÓN R, GARCÍA-REY C. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrobial Chemotherapy 2002; 50, S2: 27-37.
18. SCOTT JA, HALL AJ, DAGAN R, DIXON JM, EYKYN SJ, FENOLL A et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996; 22: 973-981.
19. KELLNER JD, MCGEER A, CETRON MS, LOW DE, BUTLER JC, MATLOW A et al. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998; 17: 279-286.
20. LEE NY, SONG JH, KIM S, PECK KR, AHN KM, LEE SI et al. Carriage of antibiotic-resistant pneumococci among Asian children multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infect Dis 2001; 32: 1463-1469.
21. DOERN GV, BRUEGGEMANN AB, HUYNH H, WINGET E, RHOMBERG P. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerging Infect Dis 1999; 5: 757-765.
22. PALLARES R, GUDIOL F, LIÑARFS J, ARIZA J, RUFI G, MURGUI L et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. New England J Med 1987; 317: 18-22.
23. CABELLOS C, ARIZA J, BARREIRO B, TUBAU F, LIÑARES J, PALLARÉS R et al. Current usefulness of procaine penicillin in the treatment of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17: 265-268.
24. GARAU J, AGUILAR L, RODRIGUEZ-CREIXEMS M, DALRE R, PEREZ-TRALLERO E, RODRIGUEZ M et al. Influence of comorbidity and severity of the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy. J Chemother 1999; 4: 266-272.
25. PEREZ-TRALLERO E, ALKORTA M, GIMENEZ MJ, VICENTE D, AGUILAR L. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother 2001; 13: 118-125.
26. PEREZ-TRALLERO E, ALKORTA M, GARCÍA-ARENZANA JM, ITURZAETA A, GOMARIZ M. In-vitro, in-vivo and exvivo studies with oral beta-lactams against Streptococcus pneumoniae. J Antimicrob Chemother 1998; 41: 629-634.
27. MUSHER DM, BARLETT JG, V. DOERN G. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch Intern Med 2001; 161: 2538-2544.
28. DOWELL SF, BUTLER JC, GIEBINK GS, JACOBS MR, JERNIGAN D, MUSHER DM et al. Acute otitis media - management and surveillance in an era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae therapeutic working group (DRSPTWG). Ped Infec Disease Jour 1999; 18: 1-9.
29. AGUILAR L, GIMENEZ MG, GARCÍA-REY C AND MARTÍN JE. New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with beta-lactam antibiotics. J Antimicrob Chemother 2002; 50: 93-100.
30. TINA TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 2003; 16: 271-277.
31. KAPLAN SL, MASON EO. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998; 4: 628-644.